Radiotherapy and chemotherapy in high-risk breast cancer
Evans, R.A.
New England Journal of Medicine 338(5): 331; Author Reply 331-332
1998
ISSN/ISBN: 0028-4793 PMID: 9446032 Document Number: 486496
Document emailed within 1 workday
Related Documents
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer Journal of Medicine 25(3-4): 241-250Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2009: Postmastectomy radiotherapy in moderate-and high-risk elderly breast cancer patients Zhonghua Zhong Liu Za Zhi 31(11): 863-866
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Kuhl, C.K. 2002: High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) Journal of Experimental and Clinical Cancer Research: Cr 21(3 Suppl): 103-106
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Taguchi, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Tanizawa, K.; Matsuura, K.; Itoh, Y. 2009: Comparison of antiemetic efficacy between single and repeated treatments with a 5-HT3 receptor antagonist in breast cancer patients with high-risk emetogenic chemotherapy Anticancer Research 29(5): 1721-1725
Altundag, K. 2018: Concurrent administration of aromatase inhibitors with chemotherapy might show better outcome in high risk hormone-receptor positive early-stage breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1559-1560
Kienle, G. 1981: Mistletoe therapy of breast cancer in comparison with chemotherapy and radiotherapy ZFA. Zeitschrift für Allgemeinmedizin 57(5): 328-337
Cinek, P.; Filip, S.; Vanasek, J.; Mericka, P.; Blaha, M.; Zouhar, M. 2007: Intensive cyclic chemotherapy and transplantation of autologous peripheral blood progenitor cells (PBPC) or whole blood in high-risk breast cancer - follow up at 10 years Experimental Oncology 29(2): 144-151
Raina, V.; Sharma, A.; Deo, S.V.; Shukla, N.K.; Mohanty, B.K.; Goel, A.; Rath, G.K. 1998: Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage IIi (T4B, NO-2, M0) breast cancer Journal of the Association of Physicians of India 46(11): 926-929
Kitagawa, D.; Saji, S. 2007: The differences of standard therapy for breast cancer between Europe/America and Japan--chemotherapy, operation,and radiotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(5): 690-693
Moorman, P.G.; Havrilesky, L.J.; Gierisch, J.M.; Coeytaux, R.R.; Lowery, W.J.; Peragallo Urrutia, R.; Dinan, M.; McBroom, A.J.; Hasselblad, V.; Sanders, G.D.; Myers, E.R. 2013: Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 31(33): 4188-4198
Zhou, J.C. 1991: Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer Zhonghua Zhong Liu Za Zhi 13(4): 291-294
Sautter-Bihl, M.L. 1999: Improved survival rate by postoperative radiotherapy in postmenopausal high risk patients with breast carcinoma Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 175(9): 472-473
Kanda, K.; Waki, S.; Uchimura, M.; Kida, H.; Narita, K.; Harada, N. 1990: A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2421-2424
Ivanov, I.; Baĭchev, G.; Betova, T. 2008: Breast lesions with moderate and high risk of invasive breast cancer--incidence and some particularities Akusherstvo i Ginekologiia 47(5): 17-21
Leonard, R.C. 1998: High-dose chemotherapy in metastatic breast cancer Lancet 351(9107): 986
Aleman, B.M.P.; van Leeuwen, F.E. 2015: Hypofractionated adjuvant radiotherapy for breast cancer: no signs of increased risk of cardiotoxicity Nederlands Tijdschrift Voor Geneeskunde 159: A8856